GHK-Cu spray is used by laboratories studying copper-peptide signaling in skin remodeling, hair follicle biology, and antioxidant pathways
Coadministered Cagrilintide and Semaglutide in Adults with Overweight or Obesity Published June 22, 2025 N Engl J Med 2025;393:635-647 DOI: 10.1056/NEJMoa2502081 Abstract Background Semaglutide at a dose of 2.4 mg has established weight-loss and cardiovascular benefits, and cagrilintide at a dose of 2.4 mg has shown promising results in early-phase trials
Adding peptides to this picture requires careful consideration
Price matters, but it comes after proof
2021), and is less anxiogenic (Benowitz et al
GHK-Cus copper properties are the main culprit behind injection site irritation a sting, itching, and welting